UPDATE : Tuesday, April 24, 2018
상단여백
Corestem’s NeuroNata-R marks increase in foreign patients
The number of foreign patients visiting Korea to use Corestem’s NeuroNata-R...
by Lee Han-soo  |  2017-12-15 16:22
라인
FDA approves Pfizer’s Remicade biosimilar
Pfizer said Wednesday that it received U.S. Food and Drug Administration’s ...
by Lee Han-soo  |  2017-12-14 17:16
라인
Samsung BioLogics’ 2nd factory gets European approval
Samsung BioLogics said Thursday that its second factory received manufactur...
by Lee Han-soo  |  2017-12-14 10:52
라인
‘Surge of gene-therapy providing hospitals to benefit Invossa’
With hospitals increasingly registering as a provider of gene therapies, Ko...
by Nam Doo-hyun  |  2017-12-12 15:59
라인
PCL shares rise despite regulator’s warning
Shares of PCL, a provider of in vitro diagnostic products, have risen again...
by Nam Doo-hyun  |  2017-12-12 11:02
라인
Oscotec shares rebound on launch of US clinical trial
Shares of Oscotec rebounded on Monday on the company’s announcement that it...
by Nam Doo-hyun  |  2017-12-11 15:50
라인
ToolGen’s shares jump on gene therapy market expectations
With rising expectations for a rapid growth of gene therapy market, investo...
by Nam Doo-hyun  |  2017-12-11 15:16
라인
MGmed to run world’s 1st postmortem DNA bank
MGmed, a Korean firm specializing in molecular diagnostic techniques for ge...
by Marian Chu  |  2017-12-08 17:11
라인
Toolgen wins German utility model for gene editing tool
Toolgen said Friday that it has completed the registration of two German ut...
by Lee Han-soo  |  2017-12-08 16:56
라인
Celltrion seeks to shift to main bourse
Biosimilar maker Celltrion is aiming to relist its stocks on the Korea Exch...
by Lee Han-soo  |  2017-12-07 11:25
라인
Medipost wins patent for Cartistem in Europe
Medipost said Wednesday that it has acquired patents on its core production...
by Lee Han-soo  |  2017-12-06 13:15
라인
MGmed emerges as largest shareholder of UK bio venture
MGmed said it has emerged as the largest stakeholder of Oxford Vacmedix (OV...
by Marian Chu  |  2017-12-06 13:00
라인
Kolon Life Science confident to make Invossa global blockbuster
Despite proved efficacy in reducing pain for osteoarthritis patients, Kolon...
by Nam Doo-hyun  |  2017-12-06 09:30
라인
ViroMed starts trial on VM202’s effect on peripheral artery disease
VM BioPharma, the U.S subsidiary of ViroMed, announced Tuesday that it has ...
by Lee Han-soo  |  2017-12-05 15:40
라인
Shares of biotech firms, listed with ‘exceptional techs,’ rise above offer price
Most of the biotechnology companies, listed on Kosdaq early this year under...
by Nam Doo-hyun  |  2017-12-05 14:38
라인
Sewon seeks p3 clinical trials for cartilage cell therapy in Japan
Sewon Cellontech said Monday that Olympus RMS has submitted phase 3 clinica...
by Lee Han-soo  |  2017-12-04 16:17
라인
Cord blood biotech firms enjoy stock price gains this year
Korean biotech firms with major pipelines in cord blood banks and umbilical...
by Nam Doo-hyun  |  2017-12-04 15:02
라인
Nature Cell’s clinical trial on Alzheimer therapy running smoothly
Nature Cell said Monday that it has injected 10 doses of Astrostem, a stem-...
by Lee Han-soo  |  2017-12-04 14:57
라인
FDA approves clinical trial for Pharmicell’s liver cirrhosis treatment
Pharmicell said Monday that the U.S. Food and Drug Administration has appro...
by Lee Han-soo  |  2017-12-04 14:57
라인
Tego Science shares surge on robust earnings
The surging of Tego Science shares on Kosdaq on Thursday drew attention, pr...
by Nam Doo-hyun  |  2017-12-01 11:48
-12345678910-
'Obese males at higher risk for bladder cancer''Obese males at higher risk for bladder cancer'
여백
Most viewed
여백
Opinion
[Column]Brokerage reports and biotech stock prices
[Column]Brokerage reports and biotech stock prices
Stigmatizing mental illness leads to high suicide rate
Stigmatizing mental illness leads to high suicide rate
Korea needs English medical media outlet
Korea needs English medical media outlet
여백
Back to Top